HHS, NIH Launch $500 Million Project to Develop Universal Vaccines to Protect Against ‘Pandemic-Prone’ Viruses

Generation Gold Standard will use traditional vaccine technology to develop universal vaccines for influenza, coronaviruses and multiple strains of viruses like H5N1 avian influenza and coronaviruses, including SARS-CoV-2, SARS-CoV-1 and MERS-CoV.